A. Buzzi

What a 60-year-old “guy” with hemophilia today possibly ask for, after having survived a decade without any treatment, and then going through the gloomy years of plasma derivatives tainted with deadly blood-borne viruses like HIV, HBV and HCV, the most appalling drug-induced catastrophe of modern medicine?

We are undeniably facing a change of paradigm, requiring and fostering adjustments by both patients and physicians. The most important indicator of the efficacy of hemostatic therapy is the frequency of bleeding, state WFH Guidelines for the Management of Hemophilia.

(»Download here full PDF version)

Andrea Buzzi, President of the Paracelso Foundation